These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37562435)

  • 1. Effects of doxofylline as an adjuvant on severe exacerbation and long-term prognosis for COPD with different clinical subtypes.
    Chen MF; He W; Huang DS; Jia H; Zhong ZS; Li N; Li SS; Xia SY
    Clin Respir J; 2023 Sep; 17(9):851-864. PubMed ID: 37562435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the clinical characteristics and treatment outcomes of patients requiring hospital admission to treat eosinophilic and neutrophilic exacerbations of COPD.
    Kang HS; Rhee CK; Kim SK; Kim JW; Lee SH; Yoon HK; Ahn JH; Kim YH
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2467-2473. PubMed ID: 27757029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics of neutrophilic, eosinophilic and mixed-type exacerbation phenotypes of COPD.
    Kandemir Y; Doğan NÖ; Yaka E; Pekdemir M; Yılmaz S
    Am J Emerg Med; 2021 Jul; 45():237-241. PubMed ID: 33041140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-IL-5 therapies for chronic obstructive pulmonary disease.
    Donovan T; Milan SJ; Wang R; Banchoff E; Bradley P; Crossingham I
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013432. PubMed ID: 33295032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The utility of inflammatory markers to predict readmissions and mortality in COPD cases with or without eosinophilia.
    Duman D; Aksoy E; Agca MC; Kocak ND; Ozmen I; Akturk UA; Gungor S; Tepetam FM; Eroglu SA; Oztas S; Karakurt Z
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2469-78. PubMed ID: 26648709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood Eosinophils and Outcomes in Severe Hospitalized Exacerbations of COPD.
    Bafadhel M; Greening NJ; Harvey-Dunstan TC; Williams JE; Morgan MD; Brightling CE; Hussain SF; Pavord ID; Singh SJ; Steiner MC
    Chest; 2016 Aug; 150(2):320-8. PubMed ID: 26851799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Blood eosinophils: a biomarker of response to glucocorticoids and increased readmissions in severe hospitalized exacerbations of COPD].
    Xue J; Cui YN; Chen P; Cai S; Chen L; Dai ZS; Chen Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2019 Jun; 42(6):426-431. PubMed ID: 31189228
    [No Abstract]   [Full Text] [Related]  

  • 8. Eosinophils in COPD Exacerbations Are Associated With Increased Readmissions.
    Couillard S; Larivée P; Courteau J; Vanasse A
    Chest; 2017 Feb; 151(2):366-373. PubMed ID: 27746201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eosinophilic and non-eosinophilic COPD patients with chronic respiratory failure: neutrophil-to-lymphocyte ratio as an exacerbation marker.
    Acartürk Tunçay E; Karakurt Z; Aksoy E; Saltürk C; Gungor S; Ciftaslan N; Irmak İ; Yavuz D; Ocakli B; Adıgüzel N
    Int J Chron Obstruct Pulmon Dis; 2017; 12():3361-3370. PubMed ID: 29200843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose oral theophylline combined with inhaled corticosteroids for people with chronic obstructive pulmonary disease and high risk of exacerbations: a RCT.
    Devereux G; Cotton S; Fielding S; McMeekin N; Barnes PJ; Briggs A; Burns G; Chaudhuri R; Chrystyn H; Davies L; Soyza A; Gompertz S; Haughney J; Innes K; Kaniewska J; Lee A; Morice A; Norrie J; Sullivan A; Wilson A; Price D
    Health Technol Assess; 2019 Jul; 23(37):1-146. PubMed ID: 31343402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutrophil to lymphocyte ratio is a better indicator of COPD exacerbation severity in neutrophilic endotypes than eosinophilic endotypes.
    Aksoy E; Karakurt Z; Gungor S; Ocakli B; Ozmen İ; Yildirim E; Tuncay E; Agca MC; Ciftaslan Goksenoglu N; Adigüzel N
    Int J Chron Obstruct Pulmon Dis; 2018; 13():2721-2730. PubMed ID: 30233162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness using higher inhaled corticosteroid dosage in patients with COPD by different blood eosinophilic counts.
    Cheng SL; Lin CH
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2341-2348. PubMed ID: 27703344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of budesonide/formoterol pressurized metered-dose inhaler on exacerbations versus formoterol in chronic obstructive pulmonary disease: The 6-month, randomized RISE (Revealing the Impact of Symbicort in reducing Exacerbations in COPD) study.
    Ferguson GT; Tashkin DP; Skärby T; Jorup C; Sandin K; Greenwood M; Pemberton K; Trudo F
    Respir Med; 2017 Nov; 132():31-41. PubMed ID: 29229103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between eosinophilic exacerbation and eosinophilic levels in stable COPD.
    Kang HS; Kim SK; Kim YH; Kim JW; Lee SH; Yoon HK; Rhee CK
    BMC Pulm Med; 2021 Mar; 21(1):74. PubMed ID: 33653314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new predictor to determine the exacerbation and treatment of chronic obstructive pulmonary disease: eosinophil/neutrophil ratio.
    Yakar Hİ; Kanbay A
    Tuberk Toraks; 2020 Sep; 68(3):260-267. PubMed ID: 33295724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eosinophilic and Neutrophilic Airway Inflammation in the Phenotyping of Mild-to-Moderate Asthma and Chronic Obstructive Pulmonary Disease.
    Górska K; Paplińska-Goryca M; Nejman-Gryz P; Goryca K; Krenke R
    COPD; 2017 Apr; 14(2):181-189. PubMed ID: 27983888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eosinophil-guided corticosteroid therapy in patients admitted to hospital with COPD exacerbation (CORTICO-COP): a multicentre, randomised, controlled, open-label, non-inferiority trial.
    Sivapalan P; Lapperre TS; Janner J; Laub RR; Moberg M; Bech CS; Eklöf J; Holm FS; Armbruster K; Sivapalan P; Mosbech C; Ali AKM; Seersholm N; Wilcke JT; Brøndum E; Sonne TP; Rønholt F; Andreassen HF; Ulrik CS; Vestbo J; Jensen JS
    Lancet Respir Med; 2019 Aug; 7(8):699-709. PubMed ID: 31122894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The inflammatory profile of exacerbations in patients with severe refractory eosinophilic asthma receiving mepolizumab (the MEX study): a prospective observational study.
    McDowell PJ; Diver S; Yang F; Borg C; Busby J; Brown V; Shrimanker R; Cox C; Brightling CE; Chaudhuri R; Pavord ID; Heaney LG;
    Lancet Respir Med; 2021 Oct; 9(10):1174-1184. PubMed ID: 33971168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal Impact of Sputum Inflammatory Phenotypes on Small Airway Dysfunction and Disease Outcomes in Asthma.
    Abdo M; Pedersen F; Kirsten AM; Veith V; Biller H; Trinkmann F; von Mutius E; Kopp M; Hansen G; Rabe KF; Bahmer T; Watz H;
    J Allergy Clin Immunol Pract; 2022 Jun; 10(6):1545-1553.e2. PubMed ID: 35257957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical features of Japanese patients with exacerbations of chronic obstructive pulmonary disease.
    Tashiro H; Kurihara Y; Takahashi K; Sadamatsu H; Haraguchi T; Tajiri R; Takamori A; Kimura S; Sueoka-Aragane N
    BMC Pulm Med; 2020 Dec; 20(1):318. PubMed ID: 33287777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.